Form D · Biotechnology
CymaBay Therapeutics, Inc.
Newark, CA · CIK 0001042074
Offering snapshot reported Aug 14, 2015 · SEC filing
- Reported sold
- $325K Offering amount: $325K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 7, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2015 | Initial | $324,999 | No comparison | 2 | SEC filing |
| Nov 1, 2013 | Amendment | $30,155,140 | $3,321,500vs Oct 11, 2013 | 335 | SEC filing |
| Oct 11, 2013 | Initial | $26,833,640 | No comparison | 264 | SEC filing |
| Nov 10, 2009 | Initial | $5,583,320 | No comparison | 27 | SEC filing |
| Jul 21, 2009 | Amendment | $27,747,055 | No comparison | 1 | SEC filing |
| Mar 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 17, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-245800
Source: Form D, filed Aug 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Bolzon | Director |
| Pol Boudes | Executive |
| Anthony Evnin | Director |
| Carl Goldfischer | Director |
| Carl Goldfischer, M.D. | Director |
| Donald Hill | Executive |
| David Karpf | Executive |
| Hari Kumar, Ph.D. | Director |
| Louis Lange | Director |
| Louis G. Lange, M.D., Ph.D. | Director |
| Charles Mc Wherter | Executive |
| Charles A. Mc Wherter, Ph. D. | Executive |
| Edward Penhoet | Director |
| Edward E. Penhoet, Ph.D. | Director |
| Paul Quinlan | Executive |
| Sujal Shah | Executive |
| Daan Van Den Noort | Director |
| Harold Van Wart | Director, Executive |
| Harold Van Wart, Ph. D. | Director, Executive |
| Kurt Von Emster | Director |
| Robert J. Wills | Director |
| Robert Zerbe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7999 Gateway Blvd Suite 130
Newark, CA, 94560
Newark, CA, 94560